Leerink Affirms Vertex Pharma (VRTX) at 'Outperform' Following ORKAMBI Approval, Guidance Update
Go back to Leerink Affirms Vertex Pharma (VRTX) at 'Outperform' Following ORKAMBI Approval, Guidance Update| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 400.76 -4.15 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $404.91 | 52 Week High | $134.71 | |||
| Open | $404.50 | 52 Week Low | $73.31 | |||
| Day High | $406.83 | P/E | N/A | |||
| Day Low | $399.29 | EPS | $-1.98 | |||
| Volume | 806,340 | |||||
